Key facts
- PS Fertility’s last known valuation is $60.0M (May 2025).
- It has raised $6.5M across 1 recorded rounds; the latest was Seed Round ($3.5M) in Apr 2025.
- Notable investors include Virginia Innovation Partnership Corporation, Virginia Venture Partners, 434, Charlottesville Angel Network.
- PS Fertility has filed 1 Form D with the SEC, most recently May 2025 ($3.5M sold to 16 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for PS Fertility
Funding rounds
1 roundsAbout PS Fertility
Operator of a medical diagnostic laboratory intended to revolutionize the diagnosis and treatment of male infertility. The company's service focuses on developing the male fertility market through scientific discovery in reproductive sciences, enabling male patients to undergo fertility testing, sperm counting, and motility measurement.
- Sector
- Healthcare
- HQ
- Charlottesville, VA, United States
- Founded
- 2019
- Employees
- 11
- Website
- psfertility.com/
- Ownership
- Privately Held (backing)
PS Fertility doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PS Fertility shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PS Fertility in its N-PORT filings yet. We sweep new filings monthly.